Самоконтроль артериального давления в современной медицинской практике

Статья содержит критический анализ Руководства по самоконтролю артериального давления (СКАД), Европейского Общества по изучению артериальной гипертонии 2008. Подробно рассмотрены теоретические вопросы, связанные с использованием метода: общая характеристика СКАД, прогностическое значение результатов, нормативы, показания к СКАД. Отдельно проанализирован метод СКАД. Освещены спорные моменты, отсутствующие в руководстве — “эффект первого измерения” и информативность длительного СКАД. Дана сравнительная характеристика двух основных современных методов измерения АД: СКАД и суточного мониторирования АД (СМАД). СКАД незаменим для рутинной оценки эффективности длительной антигипертензивной терапии. “Прерогативой” СМАД является оценка исходного уровня АД у пациентов с АГ, в т.ч. диагностика скрытой АГ, и обследование в “сложных” случаях недостаточной эффективности лечения. В целом, два метода являются взаимодополняющими. Выход русского перевода Руководства, несомненно, повысит интерес врачей к СКАД, поможет преодолеть сохраняющийся по отношению к этому методу скептицизм. В итоге все это будет способствовать повышению качества обследования и лечения больных АГ в России.

1. Ayman P., Goldshine A.D. Blood pressure determinations by patients with essential hypertension. The difference between clinic and home readings before treatment. Am J Med Sci 1940; 200: 465-74.

2. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5 (1): 93-8.

3. O’Brien E., Sheridan J, O’Malley K. Dippers and non-dippers. Lancet 1988; 2: 397.

4. O’Brien E. Replacing of mercury sphygmamanometers. BMJ 2000; 320: 815-8.

5. Asmar R, Zanchetti A. Guidelines for the use of self blood pressure monitoring: a summary report of the first international consensus conference. J Hypertens 2000; 18: 493-508.

6. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1005-87.

7. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.

8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-72.

9. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2000; 26: 1505-30.

10. Руководство Европейского Общества по Артериальной гипертензии по контролю артериального давления в домашних условиях: итоговый отчет Конференции Второго Международного Консенсуса по контролю артериального давления в домашних условиях. Артериальная гипертензия 2009; 1: 4-41.

11. Recommendations for Blood Pressure Measurements in Humans and Experimental Animals. Part I: Blood Pressure Measurement in Humans. A statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Circulation 2005; 111: 697-716.

12. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure. J Hypertens 2003; 21: 821-48.

13. Staessen JA, Thijs L, Fagard G, et al. Predicting cardiovascular risk using convential vs ambulatory blood presuure in older patients with systolic hypertension. JAMA 1999; 282: 539-46.

14. Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 2005; 45: 240-5.

15. Kleinert HD, Harshfield GA, Pickering TG, et al. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 1984; 6: 574-8.

16. Verdecchia P, Bentivoglio M, Providenza M, et al. Reliability of home self-recorded arterial pressure in essential hypertension in relation to the stage of the desease. In: “Blood pressure recording in the management of hypertension. Rome: Pozzi 1985; 40-2.

17. Abe H, Yokouchi M, Saitoh F, et al. Hypertensive complications and home blood pressure measured in the doctor’s office. J Clin Hypertens 1987; 3: 661-9.

18. Jamerson KA, Schork N, Julius S. Effect of home blood pressure and gender on estimates of the familiar aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension 1992; 20: 314-8.

19. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-7.

20. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension 2006; 47: 846-53.

21. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-9.

22. Tsunoda S, Kawano Y, Horio T, et al. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25: 788-94.

23. Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biologocal mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR). BMC Public Health 2009; 9(1): 293.

24. Beevers G, Lip GY, O’Brien E. ABC of hypertension: blood pressure measurement. Part II: Conventional sphygmomanometry: technique of auscultatory blood pressure measurement. BMJ 2001; 322: 1043-7.

25. Рогоза А.Н., Ощепкова Е.В., Цанареишвили Е.В., Гориева Ш.Б. Современные неинвазивные методы измерения артериального давления для диагностики артериальной гипертонии и оценки эффективности антигипертензивной терапии. Москва 2007; 72 c.

26. Parati G, Asmar R, Stergiou GS. Self blood pressure monitoring at home by wrist devices: a reliable approach? J Hypertens 2002; 20: 573-8.

27. O’Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recomendations of the European Society of Hypertension. BMJ 2001; 322: 531-6.

28. Logan AG, Dunai A, McIsaaac WJ, et al. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens 2008; 26: 446-52.

29. Tisler A, Dunai I, Keszei A, et al. Primary-care physicians views about the use of home/self blood pressure monitoring: nationwide survey in Hungary. J Hypertens 2006; 34: 1729-35.

30. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777-83.

31. Stergiou GS, Baibas NM, Kalogeropoulos PG. Cardiovascular risk prediction based on home blood pressure measurement: the Didima study. J Hypertens 2007; 25: 1590-6.

32. Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by home «morning» versus «evening» blood pressure values: the Ohasama study. Hypertension 2006; 48: 737-43.

33. Mengden T, Chamontin B, Phong CN, et al. User procedure for self-measurement of blood pressure, first International ConsensusConference on Self Blood Pressure Measurement. Blood Press Monit 2000; 5: 111-29.

34. Ohkubo T, Asayama K, Kikuya M, et al. How many times should blood pressure at home for better prediction of stroke risk? Ten -year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099-104.

35. Stergiou GS, Skeva II, Zoubaki AS, Mountokalakis TD. Selfmonitoring of blood pressure at home: how many measurements are needed? J Hypertens 1998; 16:725-31.

36. Stergiou GS, Baibas NM, Gantzarou AP, et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens 2002; 15: 101-4.

37. Stergiou GS, Parati G. The optimal schedule for self-monitoring of blood pressure by patients at home. J Hypertens 2007; 25: 1992-7.

38. Imai Y, Obara T, Okubo T. How many times should we ask subjects to measure blood presuure at home on each occasion. J Hypertens 2007; 25: 1987-91.

39. Цагареишвили Е.В., Ощепкова Е.В., Буниатян М.С. и др. Эффект “первого измерения” при самоконтроле АД больными гипертонической болезнью. Научно-практическая конференция “Пути снижения заболеваемости и смертности от сердечно-сосудистых заболеваний”. Москва 2003; 63 с.

40. Ощепкова Е.В., Цагареишвили Е.В., Рогоза А.Н. Метод самоконтроля артериального давления (возможности и ограничения). Cons med 2006; 11: 52-5.

41. Горбунов В.М., Оганов Р.Г., Платонова Е.В., Деев А.Д. Сравнительная информативность трех методов измерения артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваск тер профил 2007; 4: 5-12.

42. Ощепкова Е.В., Цагареишвили Е.В., Рогоза А, Н. Новые возможности метода самоконтроля артериального давления в оценке его ритмических изменений и эффективности антигипертензивной терапии. Актуальные вопросы болезней сердца и сосудов 2008; 3: 65-70.

43. Thijs L, Staessen J, Celis H, et al. Reference values of self-recorded blood pressure. A meta-analysis of summary data. Arch Intern Med 1998; 158: 481-8.

44. Thijs L, Staessen J, Celis H, et al. Self-recorded blood pressure in normotensive and hypertensive patients: a meta-analysis of individual patient data. Blood Press Monit 1999; 4: 77-86.

45. Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13: 1377-90.

46. Saito S, Asayama K, Ohkubo T, et al. The second progress report on the Hypertension Objective treatment based on measurements by Electrical Devices of Blood Pressure (HOMED-BP) study. Blood Press Monit 2004; 9: 243-7.

47. Fujiwara T, Nishimura T, Ohkubo T, Imai Y. Rationale and design of (HOMED-BP) Study: hypertension objective treatment based on measurements by electrical devices of blood pressure study. Blood Press Monit 2002; 7: 77-82.

48. Staessen JA, Den HE, Celis H, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician office: a randomized controlled trial. JAMA 2004; 291: 955-64.

49. Verberk W, Kroon AA, Lenders JW, et al. Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trials. Hypertension 2007; 50: 1019-25.

50. Pickering TG, Coats A, Mallion JM, et al. Task Force V: White coat hypertension. Blood Press Monit 1999; 4: 333-41.

51. Диагностика и лечение артериальной гипертензии. Российские рекомедации (третий пересмотр). Кардиоваск тер профил 2008; 6 (приложение 2): стр. 3-32.

52. Platonova EV, Deev AD, Gorbunov VM, et al. Home blood pressure measurements in elderly patients: prevalence and predictors of isolated office and ambulatory hypertension. J Hypertens 2009; 27 (Suppl 4): S411.

53. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of ”Masked” hypertension and ”White-coat” hypertension detected by 24-h ambulatory blood pressure monitoring. JACC 2005; 46: 508-15.

54. Fagard RH, Cornelissen A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25: 2193-8.

55. Palatini P. Masked hypertension: how can the condition be detected? Blood Press Monit 2004; 9: 297-9.

56. Verberk WJ, Kessels AGH, de Leeuw PW. Prevalence, causes and consequences of masked hypertension: a meta-analysis. Am J Hypertens 2008; 21: 969-75.

57. Горбунов В.М., Смирнова М.И. Современные проблемы оценки эффективности антигипертензивной терапии: скрытая неэффективность лечения и “гипертония белого халата”. РФК 2009; 3: 76-82.

58. Banegas JR, Segura J, Sobrino J, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension 2007; 49: 62-8.

59. Горбунов В.М., Смирнова М.И., Андреева Г.Ф. и др. Распространенность и предикторы скрытой неэффективности лечения артериальной гипертонии при использовании различных препаратов. Кардиология 2009; 2: 32-7.

60. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure mpnitoring pattern of resistant hypertension. Blood Press Monit 2003; 8: 181-5.

61. Горбунов В.М. Использование СМАД для оценки эффективности антигипертензивной терапии. ДЕКОМ 2006; 48 с.

62. Oikawa T, Obara T, Ohkubo T, et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 2006; 24: 1737-43.

63. Alsuwaida A, Parkes R, So J, et al. High prevalence of masked hypertension in treated hypertensive patients with type 2 diabetes mellitus. Saudi J Kidney Dis Transplant 2006; 17 (3): 326-37.

64. Pickering TG, Kario K. Masked hypertension a review. Hypertens Res 2007;30:479-88.

65. Зайцев В.П. Вариант психологического теста Mini-Mult. Психолог ж 1981; 2(3): 118-23.

66. Горбунов В.М., Смирнова М.И., Андреева Г.Ф., Деев А.Д. Влияние спираприла на показатели клинического и амбулаторного артериального давления и их соотношение у больных артериальной гипертонией. РКЖ 2009; 1: 57-61.

67. Rizzoni D, Castellano M, Muiesan ML, et al. Beyond trough: peak ratio: a new index of the smoothness of the antihypertensive effect of a drug. High Blood Press 1997; 6: 110-5.

68. Горбунов В.М. Некоторые вопросы практического использования суточного мониторирования артериального давления. Клиницист 2008; 3: 30-40.

69. Verberk W, Kroon AA, Kessels AG, et al. The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens 2006; 24: 1541-8.

70. Kario K. Early morning risk management in hypertension. Current Medicine Group Ltd., 2005, 68 pp.

71. Stergiou GS, Alamara CV, Skeva II, Mountokalakis TD. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring. J Hum Hypertens 2004; 18: 85-9.

72. Verdecchia P, Angeli F, Mazzotta G, et al. Home blood pressure measurements will not replace 24-hour ambulatory blood pressure monitoring. Hypertension 2009; 54: 188-95.

73. Martinez MA, Sancho T, Garcia P, et al. Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage. Blood Press Monit 2006; 11: 207-13.

74. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. New Engl J Med 2003; 348: 2407-15.

75. Dolan E, Stanton AV, Thom S, et al. on behalf of the ASCOT investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients — an AngloScandinavian cardiac outcomes trial substudy. J Hypertens 2009; 27: 876-85.

76. Parati G, Omboni S, Bilo G. Home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension 2009; 54: 181-7.

77. Горбунов В.М., Оганов Р.Г., Деев А.Д. Сравнительная информативность различных способов анализа результатов суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваск тер профил 2003; 1: 17-25.

78. Parati G, Bilo G. Clinical relevance of day-to-day blood pressure and heart rate variability: new information from home self-measurements. Hypertension 2008; 52: 1006-8.

79. Boggia J, Li Y, Thijs L, et al. International Database of Ambulatory Blood Presuure Monitoring in Relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219- 29.

80. Staessen JA, Beilin L, Parati G, et al. Task Force IV: Clinical use of ambulatory blood pressure monitoring. Blood Press Monit 1999; 4: 319-31.

81. Stergiou GS, Argyraki KK, Moyssakis I, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. J Hypertens 2007; 20: 616-21.

82. The IPPPSH Collaborative Group. Cardiovascular risk and factors in a randomized trial of treatment based on the beta-blocker oxprenolol in the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens 1985; 3: 379-92.

83. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients in the Glasgow blood pressure clinic. J Hypertens 1986; 4: 14156.

84. Bulpitt CJ, Beevers GD, Butler A, et al. Treated blood pressure, rather than pretreatment, predicts survival in hypertensive patients: a report from DHSS hypertension care computing project. J Hypertens 1988; 6: 627-32.

85. Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA Study. J Hypertens 1995; 13: 1377-90.